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AbsTrACT
Purpose To evaluate the role of right-angled 
vessels (RAVs) during disease progression in macular 
telangiectasia type 2 (MacTel).
Methods In this study, 100 eyes of 52 patients and 52 
eyes of 26 age-related controls were examined using 
fundus photography, spectral-domain optical coherence 
tomography (SD-OCT), OCT angiography (OCT-A) and 
fundus fluorescein angiography (FFA). Two masked 
readers graded fundus photographs of patients’ eyes 
into five disease stages according to Gass and Blodi, and 
evaluated all eyes for the presence of RAVs. If RAVs were 
present, their course and origin (arterial vs venous) was 
evaluated with OCT-A and FFA, respectively. Additionally, 
we looked for morphological correlates of these vessels 
on SD-OCT scans. Neovascular eyes were analysed for 
the presence of RAVs and for morphological changes on 
formation of neovascularisations (NVs).
results In OCT-A, RAVs were already detectable in 
eyes with early stages (1 to 2), could be tracked from 
superficial to outer retinal layers and were shown to 
form anastomoses in the outer retina with disease 
progression. These vessels were of both arterial and 
venous origin as shown by early phase FFA. Dilated 
capillaries and RAVs in OCT-A corresponded to hyper-
reflective alterations of the outer retina on SD-OCT scans. 
In 19/19 eyes, NVs were associated with the presence 
of RAVs, and RAVs were shown to directly connect to 
neovascular complexes and to undergo morphological 
changes upon NV formation.
Conclusions The results emphasise the role of RAVs 
during disease progression from an early stage on and 
demonstrate their involvement in the development of 
secondary NVs in MacTel.
InTroduCTIon
Macular telangiectasia (MacTel) type 2 is a bilat-
eral macular disease that is characterised by both 
neurodegenerative and vascular alterations, and a 
slowly progressive disease course.1 Structural and 
functional alterations are usually limited to an 
oval-shaped area centred on the fovea, of approx-
imately 8° horizontal and 5° vertical diameter. In 
1993, Gass and Blodi suggested five stages based 
on funduscopic and angiographic findings2: stage 1 
is characterised by the lack of typical funduscopic 
findings, but the presence of leakage in fluorescein 
angiography; stage 2 is defined by a loss of retinal 
transparency (retinal greying) and stage 3 by the 
occurrence of prominent, blunted retinal vessels 
that do not seem to narrow towards the foveola, 
but to dive into deeper retinal layers at a right angle 
(‘right-angled vessels’, RAVs). These vessels were 
described to occur either in a solitary or multiple 
form, and to frequently be associated with ectatic 
capillaries.1 Stage 4 is defined by the occurrence of 
intraretinal pigment migration and stage 5 by the 
presence of secondary neovascularisations (NVs).
Secondary NVs are considered a rare but 
vision-threatening complication in MacTel.1 2 
Their origin still remains controversial. Thus far, 
neovascular complexes were commonly thought to 
originate rather from the retinal vasculature than 
from the choroid, developing retinal–retinal anas-
tomoses or chorioretinal anastomoses.2–4 Different 
studies observed morphological vascular changes 
preceding NV development, for example, dilation, 
elongation or apparent discontinuation of vessels—
and especially of RAVs—as well as the occurrence 
of concomitant pigment plaques.2 3 5
Until recently, available imaging methods enabled 
only a two-dimensional illustration of the retinal/
choroidal vasculature. An en face differentiation 
into superficial and deep retinal plexus and exact 
allocation of vessels to different retinal layers has 
so far not been feasible. With the advent of optical 
coherence tomography angiography (OCT-A), the 
awareness of this has markedly increased. Showing 
motion contrast in the retina, OCT-A can provide 
detailed three-dimensional images of the perfused 
microvasculature in different retinal layers and in 
the choroid.6–11 In this study, we evaluate the role 
of microvascular changes and especially of RAVs 
during disease progression and NV development 
and take advantage of currently available imaging 
methods for a precise illustration of the retinal 
microvasculature in eyes with MacTel.
MeThods
In this cross-sectional analysis, participants were 
selected from the Natural History and Observation 
Study from a single-centre cohort at the Depart-
ment of Ophthalmology, University Hospital of 
Bonn, Germany. Protocol details of the study 
have been published previously.12 The diagnosis 
of MacTel type 2 was based on funduscopy, spec-
tral-domain OCT (SD-OCT), macular pigment 
optical density and fundus fluorescein angiog-
raphy (FFA).1 Controls were age-matched healthy 
probands without any evidence of retinal diseases 
and clear media. Patients and controls underwent 
a full clinical examination, including best-corrected 
visual acuity testing, dilated funduscopy, SD-OCT 
(volume scans of 15 mm×10 mm [high-resolu-
tion mode, 97 scans], Spectralis; Heidelberg Engi-
neering, Heidelberg, Germany) and OCT-A (scans 
of 3 mm×3 mm [312 horizontal A-scans, Angio 
mode], Zeiss PLEX Elite 9000; Carl Zeiss Meditec, 
Dublin, California, USA). Additionally, fluorescein 
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angiography (SLO; Heidelberg Engineering) was performed in 
patients only. Inclusion criteria were a complete imaging data set 
and sufficient imaging quality.
Images of patients’ eyes prior to the development of secondary 
NVs were analysed, if available. All imaging modalities showing 
the morphology of the macular vasculature (including FFA, 
fundus autofluorescence [FAF], infrared imaging) were therefore 
included.
Image processing and analysis
For segmentation of the images (OCT-A and SD-OCT) into 
superficial, deep and avascular layers, and into choriocapil-
laris and outer retina–choriocapillaris layer (ORCC), a semi-
automated segmentation algorithm was applied. Subsequently, 
segmentation lines were manually adjusted considering indi-
vidual layer variation and shift in the context of the disease.13 
Segmentation layers were based on relevant anatomical struc-
tures: the superficial layer was defined reaching from the outer 
boundary of the retinal nerve fibre layer to the outer boundary 
of the inner plexiform layer (IPL), the deep layer reaching from 
the outer boundary of IPL to the outer boundary of the outer 
plexiform layer (OPL) and the avascular layer reaching from 
the outer boundary of OPL to the outer boundary of the retinal 
pigment epithelium (RPE). The latter layer usually does not 
contain vascular networks in healthy subjects. The CC layer was 
defined as a slab reaching from the outer boundary of Bruch’s 
membrane to approximately 20 µm below Bruch’s membrane. 
Additionally, for a good visualisation of NV membranes, the 
ORCC slab extending from the outer boundary of the OPL to 8 
µm below Bruch’s membrane was analysed.
After segmentation, image data were processed by a general 
sliding slab method in order to reduce decorrelation tail artefacts 
from superimposing structures. This method was previously 
described elsewhere.14 15
Image grading
Patients’ eyes were graded according to the staging system 
proposed by Gass and Blodi2 based on the evaluation of fundus 
photographs and FFA. Furthermore, all eyes were analysed for 
the presence or absence of RAVs in fundus photography and 
OCT-A.
RAVs were defined as follows: in funduscopy/fundus photog-
raphy visible, blunted, slightly dilated vessels that are mainly 
located in the temporal parafovea, and that seem not to narrow 
towards the foveola, but suddenly dive at a right angle into 
deeper retinal layers (definition according to the morpholog-
ical criteria described by Gass and Blodi).1 2 In OCT-A, vessels 
bearing the same characteristics (dilation and apparent discontin-
uation caused by a vertical deviation from superficial to deeper 
retinal layers) were likewise defined as RAVs.
Vessels that met the criteria of RAVs in OCT-A were addition-
ally grouped according to their venous or arterial origin based 
on early phase FFA.
SD-OCT images were graded for the presence or absence of 
hyper-reflective lesions located in the outer retina, and images 
were correlated to OCT-A data. Grading was performed in a 
masked fashion by two independent graders (STz and CM). 
In case of disagreement between graders, a third grader (STh) 
performed the final grading.
statistical analyses
Statistical analyses were performed using GraphPad Prism V.7.0 
(GraphPad Software, San Diego, California, USA). Interobserver 
agreement between graders 1 and 2 was calculated using Cohen’s 
kappa (κ) test.
resulTs
Data of 100 eyes of 52 patients (mean age of 62.3 years±SD 
6.3; range, 49–78) and 52 eyes of 26 age-related controls (mean 
age of 61.2 years±SD 5.9; range, 45–75) were analysed. Four 
eyes were excluded from our analysis due to insufficient OCT-A 
image quality. Image grading revealed 16 stage 1, 13 stage 2, 29 
stage 3, 23 stage 4 and 19 stage 5 eyes.
detection and imaging of rAVs
According to the staging system of Gass and Blodi, RAVs are 
funduscopically not visible in early disease stages 1 and 2. 
However, OCT-A imaging detected dilated, vertically running 
vessels that were defined as RAVs (see Methods section) in 
11/16 (69%) patients’ eyes assigned to stage 1, and in 10/13 
(77%) patients’ eyes assigned to stage 2. These vessels were 
shown to dive into deeper retinal layers and form anastomoses 
that could be visualised in the deep and/or avascular layer by 
OCT-A imaging (figure 1). Notably, the extent of abnormal 
vessel formation in the avascular layer seemed to increase with 
disease progression (figure 2). Further, an association of RAVs 
with a rarefication of surrounding vessels in the deep plexus was 
observed in patients’ eyes and seemed to increase with disease 
progression (figures 1–3). In eyes with advanced disease stages, 
enlarged intervascular spaces and rarefied vessels surrounding 
RAVs could also be detected in the superficial plexus. In none of 
the control eyes, similar vascular changes were observed.
A subgroup analysis of eyes with a largely preserved retinal 
architecture and thus well-definable retinal layers (n=19, stages 
1 to 3; exemplary eyes are shown in figure 2, four upper rows) 
likewise revealed the presence of pathological vascular structures 
in the deep and avascular layers. Notably, in four eyes (all stage 
1), vascular alterations were detectable in the superficial and 
deep layers, but did not seem to infiltrate the avascular layer 
(two out of these eyes are shown in the two upper rows of figure 
2).
Interestingly, we observed an irregular appearance of vascular 
structures and an apparent increase of flow voids in the chorio-
capillaris of eyes with advanced disease stages (figures 2 and 3).
Comparison of OCT-A and conventional SD-OCT data 
revealed a high correlation of these dilated capillaries (and espe-
cially RAVs) in OCT-A to hyper-reflective intraretinal lesions at 
the level of the deep retinal plexus and the avascular layer (figure 
2). Both alterations (in SD-OCT and OCT-A) were detectable in 
all disease stages and showed a parallel enlargement and exten-
sion to deeper layers/the avascular layer with disease progres-
sion. The degree of these changes, however, varied strongly 
between eyes. In eyes with early disease stages (see figure 2, four 
upper rows), we observed only scattered dilated capillaries in 
OCT-A that correlated to small, solitary spot-like hyper-reflec-
tive lesions on SD-OCT scans. In eyes with advanced disease 
stages, distinctly dilated vessels and their courses from inner to 
outer retinal layers could be directly correlated to large hyper-re-
flective intraretinal lesions that extended over several layers 
(figure 2, four lower rows).
The occurrence of concomitant funduscopically visible 
pigment plaques (in stages ≥4) increased the intensity of the 
signal as well as the retrograde signal loss beyond the lesions 
causing pronounced shadowing effects on underlying structures. 
Control eyes showed neither hyper-reflective signalling beyond 
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Figure 1 Right-angled vessels (RAVs) are present in early disease stages as shown by optical coherence tomography angiography (OCT-A) before 
they are visible in funduscopy. Fundus photographs and OCT-A (whole retina, superficial, deep and avascular layer) of exemplary eyes of different 
disease stages. RAVs and their courses are marked by yellow arrowheads. Anastomoses are marked with a yellow-dotted box in the deep and 
avascular layer, respectively. Note the increasing rarefication of vessels surrounding RAVs with disease progression in the deep and superficial layers.
the level of the OPL in SD-OCT, nor dilated capillaries/RAVs in 
OCT-A.
Analyses of FFA images showed that in all eyes (non-neovas-
cular and neovascular) with available FFA (73/100), the observed 
anastomotic complexes in the outer retina were formed by 
vessels of both venous and arterial origin (figure 3). Notably, in 
most cases, these anastomoses were formed by vessels from the 
superior and inferior arcade, and usually consisted of pairs of at 
least one arterial and two venous vessels (figure 3).
secondary nVs in oCT-A
In 19/19 (100%) eyes that were classified as neovascular 
(neovascular membranes±haemorrhages, oedema), complexes 
of neovascular vessels were detectable in OCT-A (best visible in 
the ORCC layer; figure 4). In all neovascular eyes, RAVs were 
present and could be tracked from superficial to outer retinal 
layers in OCT-A. Notably, these vessels seemed to be directly 
connected to subretinal neovascular complexes, as shown in 
figure 4.
In cases where longitudinal data prior to NV development 
were available (n=12), we observed these vessels to undergo 
morphological transformation with thickening, deformation 
(stretching, elongation, dilation) and apparent discontinuation 
with disease progression and NV formation (figure 5).
Interobserver agreement
The strength of interobserver agreement (between graders 
1 and 2) was highest for the presence or absence of RAVs in 
OCT-A (κ=0.83). Subdivision of eyes into disease stages 1 to 5 
according to Gass and Blodi was best for advanced disease stages 
(3 to 5; κ=0.72), and lower but still adequate for early stages (1 
to 2; κ=0.62).
dIsCussIon
According to the clinical staging system proposed by Gass and 
Blodi, the presence of so-called RAVs in funduscopy is consid-
ered a sign for a rather advanced disease form (stage 3 out of 
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Figure 2 Intraretinal hyper-reflective lesions in the outer retina as observed in spectral-domain optical coherence tomography (SD-OCT) correspond 
to dilated capillaries and vertically running vessels (right-angled vessels, RAVs) in OCT angiography (OCT-A). These lesions are most pronounced in 
advanced, but may also be observed in early disease stages, and in eyes with a largely preserved retinal architecture (four upper rows). In the latter, 
prominent cut vessels could be visualised both in the deep and in the avascular layer in SD-OCT and OCT-A, respectively. Note that the intensity of the 
signal as well as the retrograde signal loss beyond the lesions increase with occurrence of concomitant pigment plaques (stages 4 and 5). Exemplary 
eyes out of different disease stages (stages 1 to 5) imaged with (from left to right) fundus photography, infrared (IR), SD-OCT and OCT-A (superficial, 
deep, avascular and choriocapillaris layer). The exact localisation of corresponding OCT -sections (longitudinal and transverse) is marked with red 
lines. Yellow arrowheads (SD-OCT) and dotted boxes (OCT-A) indicate abnormal vessels in the deep and in the avascular layer. A red-dotted box 
indicates the visible neovascular complex in the choriocapillaris layer of the stage 5 eye. The red arrowhead points out a large shadowing artefact in 
the choriocapillaris layer caused by an overlying pigment plaque in the stage 4 eye. Note the apparently increasing flow voids in the choriocapillaris 
layer in eyes with advanced disease stages.
5) in MacTel.2 However, this classification is solely based on 
morphological findings as seen in funduscopy and FFA and does 
not consider findings from currently available imaging modali-
ties such as OCT or OCT-A. In this study, we evaluated and illus-
trated the retinal microvasculature with multimodal imaging and 
focused on the role of RAVs in the context of disease progression 
in MacTel.
By means of OCT-A, we showed that vessels reflecting the 
morphological characteristics of RAVs could already be detected 
in early disease stages (stages 1 to 2) and before they became 
visible in funduscopy. Of course, other imaging modalities (eg, 
scanning laser ophthalmoscopy) with a higher contrast resolu-
tion and confocal lighting systems may also result in a better 
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Figure 3 Right-angled vessels may be of venous and/ or arterial origin and may be tracked from superficial to deep retinal layers, forming 
anastomoses in the deep and/or avascular layer. Note the extension of vascular alterations to the outer retina (especially avascular layer) as well as 
the increasing rarefication of vessels with disease progression. Early phase fundus fluorescein angiography (FFA) and optical coherence tomography 
angiography (whole retina, superficial, deep, avascular and choriocapillaris layer) in exemplary eyes of different disease stages. Venous vessels are 
marked with blue, arterial vessels with red arrowheads. The red-dotted box indicates the visible neovascular complex in the choriocapillaris layer of 
the stage 5 eye.
visualisation and thus earlier detection of RAVs when compared 
with conventional funduscopy/fundus photography.
Our findings indicate that RAVs, and vascular alterations in 
general, may be affected earlier than previously expected.
Recent OCT-A studies in MacTel revealed vascular alterations, 
for example, a reduced vessel density, to possibly originate in 
the deep vascular plexus, and to further extend to the superficial 
plexus and the outer retina with disease progression.16–18 This is 
in accordance with our results showing an association of RAVs 
and a rarefication of surrounding vessels in the deep layer that 
seemed to increase with disease progression, and was also detect-
able in the superficial layer of eyes with advanced disease stages.
While alterations of the retinal vasculature have been described 
in detail, the role of vascular changes in the choriocapillaris and 
choroid in MacTel is still obscure. So far, the involvement of 
choroidal vessels in the context of secondary NVs in MacTel 
has been controversially discussed.4 5 19 A potential affection of 
the choroidal vasculature in eyes with non-proliferative disease 
stages, however, has not been unravelled so far. In this study, 
we found increasing flow voids and irregularities in the chorio-
capillaris of eyes with advanced (but non-proliferative) disease 
stages. This finding, however, must be interpreted with caution 
as superimposing structures (eg, large vessels, pigment plaques) 
cause shadowing artefacts and may thus reinforce the impression 
of an altered choriocapillaris structure. Nevertheless, structural 
alterations of the choriocapillaris in eyes with non-proliferative 
disease stages are conceivable and might precede the develop-
ment of secondary NVs. Further studies are warranted in order 
to verify and if applicable quantify these alterations and further 
assess underlying pathophysiological mechanisms.
The comparative analyses of OCT-A and SD-OCT data in this 
study revealed a direct correlation of abnormally dilated capil-
laries, and especially RAVs, in the deep retinal plexus as illus-
trated by OCT-A and hyper-reflective lesions in the outer retina 
as shown by SD-OCT. Both alterations were found to be present 
in all disease stages, and a gradual increase and extension to 
deeper retinal layers, including the avascular layer, was observed 
with disease progression. Our results are in line with previous 
observations of Baumüller et al, who first described the presence 
of hyper-reflective spots in the outer retina of eyes with MacTel 
and discussed these changes to possibly represent altered retinal 
capillaries.20 In the context of current and future clinical trials as 
well as in daily clinical practice, these findings might be helpful 
for a better judgement of the disease stage and progression.
So far, RAVs were believed to represent mainly dilated 
venules, which is probably true for most of those vessels, that we 
can observe in funduscopy. Yannuzzi et al, however, proposed 
some of these vessels to be arteriolar in nature and to form 
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Figure 4 Right-angled vessels (marked with yellow arrowheads) directly connect to neovascular subretinal complexes (marked with a red-dotted 
box). Three exemplary eyes with secondary neovascularisation (NV) development in optical coherence tomography angiography (whole retina, 
superficial, deep and outer retina–choriocapillaris [ORCC] layers). NV complexes are best visible in ORCC.
retinal–retinal anastomoses.5 In accordance with these findings, 
we showed examples of arterial vessels with similar characteris-
tics as RAVs (prominent, dilated, diving in a right angle into the 
deeper retina) by means of OCT-A and FAF. Also, we showed 
that anastomoses in the outer retina are connected and thus 
probably fed and drained by these superficially visible, bending 
vessels of arterial and venous origin. Interestingly, the formation 
of anastomoses and the extent of abnormal vessel formation in 
the avascular layer seemed to increase with disease progression. 
As we observed vascular structures in the avascular layer to occur 
even in eyes with a preserved retinal architecture (see figure 2, 
four upper rows), we concluded that this phenomenon was not 
solely simulated by a progressive collapse of retinal layers and 
increasing atrophy, but conceivably by a real downward growth 
or shift of pathological vessels to the outer retina. Findings from 
present OCT-A studies that proposed vascular changes to arise in 
the deep vascular plexus, and to extend to more superficial and 
deeper retinal layers with disease progression,16 19 may further 
support our presumption of a gradual downgrowth of patholog-
ical vessels. Our findings are also in line with recently published 
data of Spaide et al, who observed a descent of vessels from the 
deep vascular plexus towards the RPE as well as the formation 
of retinal–retinal and retinal–choroidal anastomoses, that were 
shown to be highly associated with the presence of RAVs in eyes 
with MacTel.21
The occurrence of secondary NVs in MacTel may overall be 
considered a rather rare but serious complication, as it may result 
in a rapid loss of visual acuity.1 2 According to current knowl-
edge, NVs may occur in every stage of the disease.1 Particular 
risk factors and the underlying pathomechanisms have not been 
unravelled so far. In this study, we showed an association of RAVs 
and NVs: In all 19 eyes with neovascular disease stage, promi-
nent RAVs connecting the inner retina to the deep neovascular 
membranes were present. Furthermore, we observed morpho-
logical changes (dilation, stretching, apparent discontinuation 
etc) of these vessels to occur prior to or parallel with NV forma-
tion. This is in accordance with findings from previous studies 
that likewise found an altered morphology of retinal vessels 
preceding the development of NVs.2 3 5 Thus, growth of RAVs 
to the outer retina may be rated as a sign of disease progression. 
Morphological alterations of these vessels may suggest a high 
risk of NV formation and should be monitored closely.
study limitations
The occurrence of atrophy and NV-associated changes resulting 
in an altered retinal architecture complicates the segmentation 
of OCT images and causes imaging artefacts that may influence 
the test results despite careful review and manual correction of 
segmentation. Furthermore, shadowing artefacts of large vessels 
and pigment plaques may impede the evaluation of subjacent 
structures (especially in the avascular and choriocapillaris layer), 
though an algorithm subtracting artefacts caused by superim-
posing structures was applied.
Our analyses in this study were limited to qualitative assess-
ments of image data. Further studies are warranted in order to 
quantitatively assess different parameters and verify our observa-
tions in eyes with different disease stages.
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Figure 5 Exemplary illustration of morphological changes of right-angled vessels and accompanying vessels (marked with yellow arrowheads) 
during disease progression and development of secondary neovascularisations (NVs) (due to availability, different imaging modalities [fundus 
autofluorescence, fluorescein angiography, infrared] are illustrated). Each case shows the same eye prior to (left column) and after NV formation (right 
column). Morphological alterations include stretching and elongation, dilation and malformation, apparent discontinuation and increasing pigment 
accumulation.
Notably, in order to ensure an even distribution of eyes with 
early and advanced disease stages, our patient cohort was accord-
ingly preselected. Thus, in our patient cohort, the distribution of 
disease stages does not reflect the normal distribution in MacTel, 
and early and neovascular disease stages are over-represented.
This study was conducted in a cross-sectional manner. Future 
collection of longitudinal data is needed in order to verify our 
results regarding a potential impact of RAVs on disease progres-
sion and NV formation.
ConClusIons
In this study, we emphasise the role of RAVs during disease 
progression and their association with the development of 
secondary NVs in MacTel. Our results point out to a direct 
correlation of abnormally dilated capillaries in OCT-A and 
hyper-reflective lesions in the outer retina in SD-OCT. We 
contribute further knowledge about the direction of vessel 
growth and proliferation that may help to understand patho-
physiological mechanisms of the disease and could function as a 
novel biomarker for disease and NV monitoring.
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